Byondis Appoints Christoph Korpus, PhD, MBA as Chief Executive Officer
Christoph has played a pivotal role in shaping the Company’s strategic transformation since his appointment as Chief Business Officer in January 2025 Company Founder Jacques Lemmens, PhD, remains as Chairman of the Board Byondis B.V., an independent biopharmace

